key: cord-0833377-r56rv46g
authors: Ghafouri-Fard, Soudeh; Khoshbakht, Tayyebeh; Hussen, Bashdar Mahmud; Jamal, Hazha Hadayat; Taheri, Mohammad; Hajiesmaeili, Mohammadreza
title: A Comprehensive Review on Function of miR-15b-5p in Malignant and Non-Malignant Disorders
date: 2022-05-02
journal: Front Oncol
DOI: 10.3389/fonc.2022.870996
sha: 4811c4dea902027aad97b4616dcfddef538124f8
doc_id: 833377
cord_uid: r56rv46g

miR-15b-5p is encoded by MIR15B gene. This gene is located on cytogenetic band 3q25.33. This miRNA participates in the pathogenesis of several cancers as well as non-malignant conditions, such as abdominal aortic aneurysm, Alzheimer’s and Parkinson’s diseases, cerebral ischemia reperfusion injury, coronary artery disease, dexamethasone induced steatosis, diabetic complications and doxorubicin-induced cardiotoxicity. In malignant conditions, both oncogenic and tumor suppressor impacts have been described for miR-15b-5p. Dysregulation of miR-15b-5p in clinical samples has been associated with poor outcome in different kinds of cancers. In this review, we discuss the role of miR-15b-5p in malignant and non-malignant conditions.

INTRODUCTION microRNAs (miRNAs) are a category of non-coding RNA with sizes about 20-24 nucleotide which participate in post-transcriptional control of gene expression (1) . This effect is exerted through modulation of stability and translation of mRNAs. The primary transcripts produced by RNA polymerase II have 5'-cap and 3'-polyadenylated tail. Then, Drosha ribonuclease III enzyme cleaves this transcript to make the stem-loop precursor miRNA with an estimated size of 70 nucleotides (2) . Finally, this transcript is processed by the Dicer ribonuclease to make the mature miRNA which can be combined into the RNA-induced silencing complex. Through incorporation into this complex, miRNAs can recognize their target transcript in a base pairing-dependent process resulting in suppression of translation or destabilization of transcript (3) .

MIR15B gene is located on cytogenetic band 3q25. 33 and encodes hsa-mir-15b. This miRNA participates in the pathogenesis of several cancers as well as non-malignant conditions, including cardiovascular disorders, neuropsychiatric diseases and metabolic conditions. This miRNA has been reported to exert oncogenic or tumor suppressor effects in different malignancies. We have searched the literature and discussed the role of miR-15b-5p in malignant and non-malignant conditions.

In bladder cancer cell lines, the long non-coding RNA (lncRNA) MAGI2-AS3 acts as a molecular sponge for miR-15b-5p. In fact, MAGI2-AS3 exerts its tumor suppressor role in bladder cancer through decreasing level of this miRNA. Meanwhile, miR-15b-5p has been found to target the tumor suppressor gene CCDC19. Taken together, MAGI2-AS3/miR-15b-5p/CCDC19 axis has been revealed to regulate progression of bladder cancer (4) .

An in vitro experiment in breast cancer cells has shown that miR-15b-5p silencing could restrain cell proliferation and invasiveness and induce apoptosis, while its up-regulation has exerted the opposite impacts. Notably, heparanase-2 (HPSE2) has been acknowledged as the target of miR-15b-5p in breast cancer cells, through which this miRNA applies its effect (5) .

In cervical cancer cells, level of the tumor suppressor lncRNA FENDRR has been shown to be decreased. This lncRNA has binding sites for miR-15a-5p and miR-15b-5p, two miRNAs that can down-regulate expression of Tubulin alpha1A (TUBA1A). Taken together, FENDRR/miR-15a/b-5p/TUBA1A molecular route has been proved to regulate progression of cervical cancer (6) .

Expression of miR-15b-5p has been reported to be surged in colon cancer cells. Treatment of HT-29 cells with a PNA against miR-15b-5p has been shown to reduce cell proliferation and activate the pro-apoptotic pathway (7) . Another research in colon cancer cells has displayed that SIRT1 suppresses metastatic ability of cells through decreasing expression of miR-15b-5p. In fact, SIRT1 disrupts the regulatory effect of AP-1 on activation of expression of miR-15b-5p via deacetylating this activation factor. miR-15b-5p can target the transcript of a central enzyme in the fatty acid oxidation, namely acyl-CoA oxidase 1 (ACOX1). Taken together, SIRT1/miR-15b-5p/ACOX1 axis has been identified as a functional route in regulation of metastatic ability of colorectal cancer cells (8) . Figure 1 displays the oncogenic role of miR-15b-5p in bladder, breast, cervical, colorectal, liver, oral, ovarian, prostate and gastric cancers.

In contrast to the previously mentioned experiment in colorectal cancer cells (7), Zhao et al. have shown that miR-15b-5p has a tumor suppressor impact in this cancer. Notably, miR-15b-5p can enhance 5-fluorouracil (5-FU)-induced apoptosis in these cells and reversed the resistance of colorectal cancer cells to this therapeutic agent. Mechanistically, miR-15b-5p exerts this impact through modulating activity of the NF-kB signaling via decreasing NF-kB1 and IKK-a levels. miR-15b-5p has been found to target the anti-apoptosis transcript XIAP (9) .

In vitro experiments in neuroblastoma cells have shown that up-regulation of miR-15a-5p, miR-15b-5p or miR-16-5p can reduce expression of MYCN transcript and N-Myc protein. On the other hand, suppression of these miRNAs could lead to enhancement of MYCN transcripts and N-Myc protein level, along with increasing half-life of its mRNA. The interaction between these miRNAs and MYCN mRNA has been proved through conducting immunoprecipitation and luciferase reporter assays. Notably, up-regulation of these miRNAs has diminished proliferation, migration, and invasiveness of neuroblastoma cells (17) . Figure 2 shows tumor suppressor role of miR-15b-5p in thyroid cancer, hepatocellular carcinoma, neuroblastoma, osteosarcoma and prostate cancer.

Lovat et al. have produced miR-15b/16-2 knockout mice for the purpose of identification of the role of this cluster. This intervention has led to development of B-cell lymphomas by age 15-18 month possibly though modulation of expression of Cyclins D2 and D1, and IGF1R. These genes participate in the regulation of proliferation and antiapoptotic pathways. Taken together, this cluster has been shown to have a tumor suppressor role in mice models of B-cell lymphoma (28) .

In xenograft models of bladder cancer, up-regulation of MAGI2-AS3 has reduced tumor volume possibly through decreasing expression of miR-15b-5p (4). Up-regulation of FENDRR, another miR-15b-5p-sponging lncRNA has exerted similar effects in xenograft models of cervical cancer (6) . In colorectal cancer cells, a single study has shown that overexpression of miR-15b-5p improves sensitivity of cells to 5-FU (9) . On the other hand, another study has indicated that SIRT1 decreases metastasis through suppression of miR-15b-5p transcription (8) . Moreover, miR-15b-5p has been demonstrated to decrease expression of PD-L1, suppress tumorigenic potential of colorectal cancer cells and increase anti-PD-1 sensitivity in colitisassociated cancer and APC min/+ models of colorectal cancer (10) .

In an animal model of osteosarcoma, over-expression of miR-15b-5p has been associated with reduced cell proliferation (22) . Table 2 shows summary of animal studies on the role of miR-15b-5p in cancers.

Expression assays in clinical samples obtained from patients with bladder cancer, breast cancer, gastric cancer, oral squamous cell carcinoma and prostate cancer have shown up-regulation of miR-15b-5p. On the other hand, this miRNA has been found to be down-regulated in head and neck cancer squamous cell carcinomas, neublastoma and thyroid cancer samples. Different studies in colorectal cancer and hepatocellular carcinoma sample have shown contradictory expression patterns (Table 3) . Moreover, dysregulation of expression of miR-15b-5p has been associated with poor clinical outcome in bladder cancer, breast cancer, head and neck/oral squamous cell carcinoma, hepatocellular carcinoma and neuroblastoma.

In vitro experiments in vascular smooth muscle cells (VSMCs) have shown that up-regulation of miR-15b-5p suppresses cell proliferation and induces apoptosis, while its knock down leads to opposite results. These effects are possibly mediated through suppression of ACSS2. Transfection of these cells with miR-15b-5p mimic or inhibitor has led to down-regulation and upregulation of ACSS2 and PTGS2, respectively. Taken together, miR-15b-5p may increase apoptosis of aortic VSMCs and suppress their proliferation through influencing ACSS2/PTGS2 axis, thus participating in the pathoetiology of abdominal aortic aneurysm (35) .

miR-15b-5p has also been shown to mediate the anti-amyloid effect of curcumin in an in vitro model of Alzheimer's disease through influencing expression of the amyloid precursor protein (36) . Moreover, the antiangiogenic effect of isopimpinellin has been attributed to its impact on induction of miR-15b-5p expression and subsequent down-regulation of angiogenic stimulators (37) .

In addition, miR-15b-5p has been shown to mediate the effects of LINC00473 in cerebral I/R injury. Experiments in a cellular model of cerebral I/R injury has shown down-regulation of LINC00473 in these cells. Up-regulation of this lncRNA has reversed the effects of oxygen glucose deprivation/reperfusion on cell viability and apoptosis as well as ROS levels. Mechanistically, LINC00473 acts as a molecular sponge for miR-15b-5p and miR-15a-5p and regulates expression of SRPK1 (38) . Table 4 shows summary of cell line studies on the role of miR-15b-5p in nonmalignant conditions.

Animal studies have highlighted the role of miR-15b-5p in different cellular processes and disorders such as angiogenesis, coronary artery disease, diabetic nephropathy, diabetic retinopathy, myocardial I/R injury, necroptosis and inflammation, Parkinson's disease and trachea inflammatory injury ( Table 5) . For instance, overexpression of miR-15b-5p has considerably suppressed arteriogenesis and angiogenesis in animal models through targeting AKT3. Remarkably, siRNA-mediated silencing of AKT3 has inhibited arteriogenesis and the rescue of blood perfusion following femoral ligation in animals (42) . Another animal study has shown that silencing of the miR-15b-5p-sponging lncRNA MALAT1 decreases atherosclerotic process (43) . miR-15b-5p has also been shown to affect diabetic nephropathy and retinopathy in animals. Assessment of transcriptome of high glucose-exposed mouse mesangial cells has shown the effect of miR-15b-5p and its downstream target BCL-2 in regulation of high glocose-induced apoptosis. Besides, db/db mice has been shown to have higher levels of urinary miR-15b-5p (47) .

Different experiments in human samples obtained from patients with acute mountain sickness, asthma-COPD overlap, coronary artery disease, diabetic foot ulcers, diabetic nephropathy, late pulmonary complications, obstructive sleep apnea and Parkinson's disease have shown dysregulation of miR-15b-5p levels ( Table 6) .

This miRNA might participate in the pathoetiology of acute mountain sickness. Levels of miR-15b-5p in the saliva have been found to be higher in individuals being resistant to this condition compared to susceptible ones. Combination of levels of miR-134-3p and miR-15b-5p could discriminate between these two groups. Thus, salivary levels of miR-134-3p and miR-15b-5p have been suggested as non-invasive markers for prediction of acute mountain sickness prior to exposure to high altitude (71) .

Although in vitro studies indicated possible role of miR-15b-5p in the pathogenesis of Alzheimer's disease (36) , serum levels of miR-15b-5p were not significantly different between patients with Alzheimer's disease and healthy subjects (72) .

miR-15b-5p has been among miRNA having lower expression in asthma-COPD overlap patients. This miRNA can distinguish between asthma-COPD overlap patients and individuals with either asthma or COPD. In fact, miR-15b-5p has been shown to be superior to other miRNAs in separation of patients with asthma-COPD overlap from similar conditions (73) . 

Myocardial infarction circ-Ttc3, Arl2 cardiomyocytes and cardiac fibroblasts

High levels of f circ-Ttc3 (which sponges miR-15b) was found to protect cardiomyocytes against ischemiarelated apoptotic death.

(Continued) Necroptosis and inflammation TGFBR3, TGF-b pathway HD11 and DT40 H2S exposure: ↑ oxidative stress and activates the TGF-b pathway by regulating miR-15b-5p/TGFBR3 axis miR-15b-5p is upregulated in H2S-induced necroptosis and inflammation.

Obstructive sleep apnea PTGS1-NF-kB-SP1 signaling human THP-1, HUVEC, and SH-SY5Y cell lines D miR-15b-5p: ↑ IHR-induced oxidative stress and ↑ MAOA hyperactivity via targeting PTGS1-NF-kB-SP1 signaling in OSA patients (59) Osteoarthritis LINC00662, GPR120 rat chondrocytes LINC00662 is downregulated in osteoarthritis, so mir-15b-5p is upregulated and GPR120 is suppressed, thus inflammatory responses and apoptosis are induced. 

Skeletal muscle atrophy lncIRS1 and IRS1 DF-1 cells LncIRS1 (which sponges mir-15b-5p) was found to regulate myoblast proliferation and differentiation in vitro via increasing IRS1.

Tendon injury circRNA-Ep400, FGF-1/ 7/9

↑↑ M2 macrophage-derived circRNA-Ep400 (which sponges mir-15b-5p): ↑ fibrosis, ↑ proliferation, and ↑ migration 

Angiogenesis zebrafish embryos Isopimpinellin: ↓ intersegmental vessels (37) Coronary artery disease 8-10-week-old male C57BL/6 mice Mice were received agomiR-15b, agomiR-NC, or cholesterol-conjugated AKT3 siRNA by multi-point injections.

miR-15b-5p expression was decreased, because of a reduced expression in EC layer of collaterals and miR-15b-5p was mainly derived from ECs. (42) ↑↑ miR-15b-5p: ↓ arteriogenesis and ↓ angiogenesis Coronary atherosclerotic heart disease Six-week old male ApoE−/−mice D MALAT1 (which sponges mir-15b-5p): ↓ atherosclerosis

Diabetic nephropathy 5 db/m mice and 5 db/db mice Higher urine miR-15b-5p levels were found in db/db mice. (47) Urinary EV miR-15b-5p levels were positively associated with urinary ACR. Diabetic retinopathy 80 Sprague-Dawley male rats With increased levels of circ_001209 (which sponges miR-15b-5p) retinal thickness was thinner in diabetic rats, and apoptosis was enhanced.

Myocardial ischemia reperfusion injury 6-8 week-old male C57/B6 mice D mir-15b-5p: ↓ arrhythmia, infarct extent and apoptosis, ↓ MDA content in the myocardial tissue by increasing levels of KCNJ2 (a target of mir-15b-5p)

Necroptosis and inflammation 40 one-day-old Ross 308 male broilers H2S exposure: ↑ necroptosis and inflammation (58) Parkinson's disease five-week-old male C57BL/6 mice D miR-15b-5p: ↓ MPTP-induced apoptosis by regulating Akt3 (63) Skeletal muscle atrophy 1-day-old chicks LncIRS1 (which sponges mir-15b-5p) was found to regulate muscle mass and muscle fibre cross-sectional area.

Eighty one-day-old Ross 308 broilers divided into two groups (control group and H2S group)

H2S exposure: ↑ mir-15b-5p miR-15b-5p reduced ATF2 levels to mediate METs release, which induces trachea inflammatory damage (70) ↑ Up-regulation; ↓ Down-regulation. In some conditions, dysregulation of this miRNA has been associated with clinicopathological parameters. For instance, in patients with coronary artery disease, dysregulation of miR-15b-5p has been associated with insufficient coronary collateral artery function (42) . Moreover, in diabetic nephropathy, Urinary exosomal levels of miR-15b-5p have been positively associated with urinary albumin-to-creatinine ratio, negatively associated with eGFR, and correlated with speedy failure in kidney function (47) .

miR-15b-5p is an example of miRNAs with dual roels in the carcinogenesis. While it is a putative oncogenic miRNA in bladder cancer, breast cancer, gastric cancer, oral squamous cell carcinoma and prostate cancer, it has been found to be down-regulated in head and neck cancer squamous cell carcinomas, neublastoma and thyroid cancer samples as compared with corresponding non-cancerous samples (75) . Moreover, in colorectal cancer and hepatocellular carcinoma, different studies have reported contradictory results.

This miRNA also participates in the pathogenesis of several non-malignant conditions, such as abdominal aortic aneurysm, Alzheimer's disease, Parkinson's disease, cerebral I/R injury, coronary artery disease, dexamethasone induced steatosis, diabetic complications and doxorubicin-induced cardiotoxicity.

miR-15b-5p has been shown to be sponged by several lncRNAs, namely MAGI2-AS3, H19, SNHG1, SNHG16, TTN-AS1, PVT1, FENDRR, SSTR5−AS1, MALAT1, ENST00000608794, CDKN2B-AS1, LINC00473, LINC00662, LINC00943, LncRNA-599547 and CDKN2B-AS1 as well as the circular RNA Circ_001209. Thus, lncRNAs and circRNAs can affect expression of this miRNA. Other possible regulatory mechanisms for modulation of expression levels of miR-15b-5p should be clarified in future studies.

NF-kB, STAT3, AKT/mTORC1, CDC42/PAK1 and bcatenin signaling pathways are signaling pathways that mediate the effects of miR-15b-5p in the carcinogenesis. Notably, this miRNA could regulate response of cancer cells to 5-FU and anti-PD-1 drugs. Thus, therapeutics modalities affecting expression of miR-15b-5p can be considered as possible ways to combat resistance to anti-cancer agents. Evidence from in vitro and in vivo studies indicates that therapeutic intervention with miR-15-5p levels can significantly influence pathological processes. Moreover, disease-associated abnormal expression pattern of this miRNA in the affected tissues potentiates it as a diagnostic biomarkers. Particularly, in bladder cancer, breast cancer, head and neck cancers, liver cancer, neuroblastoma, oral squamous cell carcinoma and thyroid cancer, abnormal expression of miR-15-5p has been associated with poor clinical outcomes indicating the role of this miRNA as a prognostic biomarker. It is expected that therapeutic modalities affect expression of miR-15-5p and amend disease-associated dysregulation of this miRNA. Therefore, expression pattern of miR-15-5p can be used to monitor disease status and response to therapeutic options.

Since both oncogenic and tumor suppressor roles have been reported for miR-15-5p, different miR-15-5p-targeting therapeutic targets can been applied in the field of cancer therapy. In tissues that this miRNA exerts tumor suppressor roles, exogenous miR-15-5p can be used to inhibit cell proliferation or induce apoptosis. This goal can be achieved by administration of chemically synthesized miR-15-5p mimics to induce expression of endogenous mature double-stranded miR-15-5p to restore function of this miRNA. Viral vectors expressing miR-15-5p are appropriate vectors for delivery of this miRNA to tumor cells. On the other hand, when miR-15-5p exerts oncogenic roles, antisense oligonucleotides and miR-15-5p sponges can be used for suppression of level of this miRNA. Although these strategies are putative therapeutic modalities for treatment of cancer, they have not been applied in the clinical setting yet.

While the prognostic impact of dysregulation of miR-15b-5p has been confirmed in different types of cancer, there is no explicit evidence for application of this miRNA as a diagnostic marker in cancers. Since miRNAs dysregulation in the circulation provides a potential way for early non-invasive diagnosis of cancer, future studies should focus on evaluation of expression levels of miR-15b-5p in different biofluids during the course of cancer to provide insights into diagnostic role of this miRNA in cancer.

SG-F wrote the manuscript and revised it. MT supervised and designed the study. TK, HJ, MH and BH collected the data and designed the figures and tables. All authors read and approved the submitted version.

This study was financially supported by Grant from Medical School of Shahid Beheshti University of Medical Sciences.

A Signature for Cancer Progression

An Update on the Role of miR-379 in Human Disorders

Regulation of microRNA Biogenesis

Long Noncoding RNA MAGI2-AS3 Regulates CCDC19 Expression by Sponging miR-15b-5p and Suppresses Bladder Cancer Progression

miR-15b-5p Promotes Growth and Metastasis in Breast Cancer by Targeting HPSE2

FENDRR Suppresses Cervical Cancer Proliferation and Invasion by Targeting miR-15a/B-5p and Regulating TUBA1A Expression

Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p. Nucleic Acid Ther (2020)

SIRT1 Suppresses Colorectal Cancer Metastasis by Transcriptional Repression of miR-15b-5p

Resensitizes Colon Cancer Cells to 5-Fluorouracil by Promoting Apoptosis via the NF-kb/XIAP

Blocking IL-17A Enhances Tumor Response to Anti-PD-1 Immunotherapy in Microsatellite Stable Colorectal Cancer

CERS6-AS1 Contributes to the Malignant Phenotypes of Colorectal Cancer Cells by Interacting With miR-15b-5p to Regulate SPTBN2

Overexpression of miR-15b-5p Promotes Gastric Cancer Metastasis by Regulating PAQR3

Treatment of Human Glioblastoma U251 Cells With Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis

LncRNA-H19 Activates CDC42/PAK1 Pathway to Promote Cell Proliferation, Migration and Invasion by Targeting miR-15b in Hepatocellular Carcinoma

miR-15b-5p Induces Endoplasmic Reticulum Stress and Apoptosis in Human Hepatocellular Carcinoma, Both In Vitro and In Vivo, by Suppressing Rab1A

Tumor-Derived Exosomal microRNA-15b-5p Augments Laryngeal Cancer by Targeting TXNIP

miR-15a-5p, miR-15b-5p, and miR-16-5p Inhibit Tumor Progression by Directly Targeting MYCN in Neuroblastoma

SNHG16 Knockdown Inhibits Tumorigenicity of Neuroblastoma in Children via miR-15b-5p/PRPS1 Axis

LncRNA MEG8 Promotes NSCLC Progression by Modulating the miR-15a-5p-miR-15b-5p/PSAT1 Axis

Inhibition of microRNA-15b-5p Attenuates the Progression of Oral Squamous Cell Carcinoma via Modulating the PTPN4/ STAT3 Axis

miR-15b Inhibits Cancer-Initiating Cell Phenotypes and Chemoresistance of Cisplatin by Targeting TRIM14 in Oral Tongue Squamous Cell Cancer

The miR-15b-5p/PDK4 Axis Regulates Osteosarcoma Proliferation Through Modulation of the Warburg Effect

TRPM2-AS Promotes the Malignancy of Osteosarcoma Cells by Targeting miR-15b-5p/PPM1D Axis

LncRNA TTN-AS1 Acts as Sponge for miR-15b-5p to Regulate FBXW7 Expression in Ovarian Cancer

miR-15b-5p Facilitates the Tumorigenicity by Targeting RECK and Predicts Tumour Recurrence in Prostate Cancer

Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs

MicroRNA−15b−5p Exerts its Tumor Repressive Role via Targeting GDI2: A Novel Insight Into the Pathogenesis of Thyroid Carcinoma

miR-15b/16-2 Deletion Promotes B-Cell Malignancies

Plasma Mir−15b−5p and Mir−590−5p for Distinguishing Patients With Bladder Cancer From Healthy Individuals

MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-Modulated Radiotherapy

Oncogenic Value of microRNA−15b−5p in Hepatocellular Carcinoma and a Bioinformatics Investigation

Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma

SSTR5−AS1 Functions as a ceRNA to Regulate CA2 by Sponging Mir−15b−5p for the Development and Prognosis of HBV−Related Hepatocellular Carcinoma

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing

Hsa−Mir−15b−5p Regulates the Proliferation and Apoptosis of Human Vascular Smooth Muscle Cells by Targeting the ACSS2/PTGS2 Axis

miR-15b-5p Targeting Amyloid Precursor Protein Is Involved in the Anti-Amyloid Eflect of Curcumin in Swapp695-HEK293 Cells

Isopimpinellin Extends Antiangiogenic Effect Through Overexpression of miR-15b-5p and Downregulating Angiogenic Stimulators

LINC00473 Protects Against Cerebral Ischemia Reperfusion Injury via Sponging miR-15b-5p and miR-15a-5p to Regulate SRPK1 Expression

MicroRNA-15b-5p Inhibits Tumor Necrosis Factor Alpha-Induced Proliferation, Migration, and Extracellular Matrix Production of Airway Smooth Muscle Cells via Targeting Yes-Associated Protein

Circular RNA circCHFR Downregulation Protects Against Oxidized Low-Density Lipoprotein-Induced Endothelial Injury via Regulation of microRNA-15b-5p/Growth Arrest and DNA Damage Inducible Gamma

Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated With Clopidogrel-Induced Hepatotoxicity in HepG2 Cells

MiR-15b-5p Regulates Collateral Artery Formation by Targeting AKT3 (Protein Kinase B-3)

MALAT1/miR-15b-5p/MAPK1 Mediates Endothelial Progenitor Cells Autophagy and Affects Coronary Atherosclerotic Heart Disease via mTOR Signaling Pathway

The lncRNA ENST00000608794 Acts as a Competing Endogenous RNA to Regulate PDK4 Expression by Sponging miR-15b-5p in Dexamethasone Induced Steatosis

Staphylococcus Aureus Triggers Induction of miR-15B-5P to Diminish DNA Repair and Deregulate Inflammatory Response in Diabetic Foot Ulcers

High Glucose-Induced Apoptosis in Human Kidney Cells was Alleviated by miR-15b-5p Mimics

High Glucose Induces Mesangial Cell Apoptosis Through miR-15b-5p and Promotes Diabetic Nephropathy by Extracellular Vesicle Delivery

Long non-Coding RNA CDKN2B-AS1 Regulates High Glucose-Induced Human Mesangial Cell Injury via Regulating the miR-15b-5p/WNT2B Axis

microRNA-15b-5p Shuttled by Mesenchymal Stem Cell-Derived Extracellular Vesicles Protects Podocytes From Diabetic Nephropathy via Downregulation of VEGF/PDK4

C-Myc-Activated USP2-AS1 Suppresses Senescence and Promotes Tumor Progression via Stabilization of E2F1 mRNA

miR-15b/16 Protects Primary Human Retinal Microvascular Endothelial Cells Against Hyperglycemia-Induced Increases in Tumor Necrosis Factor Alpha and Suppressor of Cytokine Signaling 3

microRNA-107 Protects Against Inflammation and Endoplasmic Reticulum Stress of Vascular Endothelial Cells via KRT1-Dependent Notch Signaling Pathway in a Mouse Model of Coronary Atherosclerosis

Sevoflurane Induces Endoplasmic Reticulum Stress Mediated Apoptosis Inmouse Hippocampal Neuronal HT22 Cells via Modulating miR-15b-5p/Rab1A Signaling Pathway

Long non-Coding RNA HCAR Promotes Endochondral Bone Repair by Upregulating VEGF and MMP13 in Hypertrophic Chondrocyte Through Sponging miR-15b-5p

miR-15b-5p Ameliorated High Glucose-Induced Podocyte Injury Through Repressing Apoptosis, Oxidative Stress, and Inflammatory Responses by Targeting Sema3A

LncRNA-599547 Contributes the Inductive Property of Dermal Papilla Cells in Cashmere Goat Through miR-15b-5p/Wnt10b Axis

Circular RNA Ttc3 Regulates Cardiac Function After Myocardial Infarction by Sponging miR-15b

Regulation of H2S-Induced Necroptosis and Inflammation in Broiler Bursa of Fabricius by the miR-15b-5p/TGFBR3 Axis and the Involvement of Oxidative Stress in This Process

MicroRNA Sequencing Analysis in Obstructive Sleep Apnea and Depression: Anti-Oxidant and MAOA-Inhibiting Effects of miR-15b-5p and miR-92b-3p Through Targeting PTGS1-NF-kb-SP1 Signaling

Long Noncoding RNA LINC00662-miR-15b-5p Mediated GPR120 Dysregulation Contributes to Osteoarthritis

LINC00943 Knockdown Attenuates MPP+-Induced Neuronal Damage via miR-15b-5p/RAB3IP Axis in SK-N-SH Cells

Upregulated lncRNA Small Nucleolar RNA Host Gene 1 Promotes 1-Methyl-4-Phenylpyridinium Ion-Induced Cytotoxicity and Reactive Oxygen Species Production Through miR-15b-5p/GSK3b Axis in Human Dopaminergic SH-SY5Y Cells

Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3b/b-Catenin Signaling Pathway Inhibits Cell Apoptosis in Parkinson's Disease

Developmental Exposure to Low Level Ambient Ultrafine Particle Air Pollution and Cognitive Dysfunction

Human microRNA hsa-miR-15b-5p Targets the RNA Template Component of the RNA-Dependent RNA Polymerase Structure in Severe Acute Respiratory Syndrome Coronavirus 2

LncIRS1 Controls Muscle Atrophy via Sponging miR-15 Family to Activate IGF1-PI3K/AKT Pathway

Exosomes From M2 Macrophage Promote Peritendinous Fibrosis Posterior Tendon Injury via the MiR-15b-5p/FGF-1/7/9 Pathway by Delivery of circRNA-Ep400

Circ_001209 Aggravates Diabetic Retinal Vascular Dysfunction Through Regulating miR-15b-5p/COL12A1

Effect of Down-Regulated miR-15b-5p Expression on Arrhythmia and Myocardial Apoptosis After Myocardial Ischemia Reperfusion Injury in Mice

Hydrogen Sulfide of Air Induces Macrophage Extracellular Traps to Aggravate Inflammatory Injury via the Regulation of miR-15b-5p on MAPK and Insulin Signals in Trachea of Chickens

The Role of Salivary miR-134-3p and miR-15b-5p as Potential Non-Invasive Predictors for Not Developing Acute Mountain Sickness

Evaluation of Hsa-Let-7d-P, Hsa-Let-7g-5p and hsa-miR-15b-5p Level in Plasma of Patients With Alzheimer's Disease Compared to Healthy Controls

Circulating microRNA-15b-5p as a Biomarker for Asthma-COPD Overlap

Expression of miR-15b-5p, miR-21-5p, and SMAD7 in Lung Tissue of Sulfur Mustard-Exposed Individuals With Long-Term Pulmonary Complications

IL-6 Genomic Variants and Risk of Prostate Cancer

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2022 Ghafouri-Fard, Khoshbakht, Hussen, Jamal, Taheri and Hajiesmaeili. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.